Novo Nordisk Stock Crashes 20% as Wegovy Sales Forecast Slashed and Eli Lilly Gains Market Share
Novo Nordisk (NYSE: NVO) investors faced a brutal wake-up call as the company's stock nosedived over 20% in pre-market trading....
healthcare investments
